<title>Alexion Pharmaceuticals, Inc. (ALXN) News & Commentary

AOL.com
About Us
Follow Us :

DJIA	15,318.23	138.38	0.91%
NASDAQ	3,482.18	30.05	0.87%
S&P 500	1,651.81	12.77	0.78%

Recent Quotes Watchlist Portfolios

market minute promo

+ Add to Portfolio

An Interview With Elemer Piros: A Strong Year For Biotechs, Looking From The Halfway Point

6/18/2013 by Seeking Alpha

Jefferies Says Analysis on Elan Supports $19/Share Takeover Bid, Lifts Price Target to $19

6/18/2013 by Benzinga

Amgen Xgeva Label Expanded - Analyst Blog

6/17/2013 by Zacks

Myriad: End to Legal Battle over Patents - Analyst Blog

6/17/2013 by Zacks

Alexion Breaks Ground on New Global Headquarters

6/17/2013 by DailyFinance

Amgen's Oncology Drug Meets Primary Endpoint - Analyst Blog

6/13/2013 by Zacks

Merrill Lynch Top Biotechnology Stocks to Buy for Big Gains

6/13/2013 by 247wallst

Alexion Pharmaceuticals, Inc. Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Ju

Alexion Pharmaceuticals, Inc. Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-12-2013 08:40 AM

6/12/2013 by Seeking Alpha

Short Interest Falls in Vertex, Rises in Biogen Idec (VRTX, BIIB)

6/12/2013 by Benzinga

Alexion to Present at the Wells Fargo 2013 Healthcare Conference

6/12/2013 by DailyFinance

See More Articles...